Literature DB >> 26483386

Carcinoma cells induce lumen filling and EMT in epithelial cells through soluble E-cadherin-mediated activation of EGFR.

Pratima U Patil1, Julia D'Ambrosio2, Landon J Inge3, Robert W Mason2, Ayyappan K Rajasekaran4.   

Abstract

In epithelial cancers, carcinoma cells coexist with normal cells. Although it is known that the tumor microenvironment (TME) plays a pivotal role in cancer progression, it is not completely understood how the tumor influences adjacent normal epithelial cells. In this study, a three-dimensional co-culture system comprising non-transformed epithelial cells (MDCK) and transformed carcinoma cells (MSV-MDCK) was used to demonstrate that carcinoma cells sequentially induce preneoplastic lumen filling and epithelial-mesenchymal transition (EMT) in epithelial cysts. MMP-9 secreted by carcinoma cells cleaves cellular E-cadherin (encoded by CDH1) from epithelial cells to generate soluble E-cadherin (sE-cad), a pro-oncogenic protein. We show that sE-cad induces EGFR activation, resulting in lumen filling in MDCK cysts. Long-term sE-cad treatment induced EMT. sE-cad caused lumen filling by induction of the ERK signaling pathway and triggered EMT through the sustained activation of the AKT pathway. Although it is known that sE-cad induces MMP-9 release and consequent EGFR activation in tumor cells, our results, for the first time, demonstrate that carcinoma cells can induce sE-cad shedding in adjacent epithelial cells, which leads to EGFR activation and the eventual transdifferentiation of the normal epithelial cells.
© 2015. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  EGFR; MMP-9; Soluble E-cadherin; Transdifferentiation

Mesh:

Substances:

Year:  2015        PMID: 26483386      PMCID: PMC4712814          DOI: 10.1242/jcs.173518

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  62 in total

1.  Loss of PALS1 expression leads to tight junction and polarity defects.

Authors:  Samuel W Straight; Kunyoo Shin; Vanessa C Fogg; Shuling Fan; Chia-Jen Liu; Michael Roh; Ben Margolis
Journal:  Mol Biol Cell       Date:  2004-01-12       Impact factor: 4.138

Review 2.  Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways.

Authors:  Lionel Larue; Alfonso Bellacosa
Journal:  Oncogene       Date:  2005-11-14       Impact factor: 9.867

3.  Requirement of Tyr-992 and Tyr-1173 in phosphorylation of the epidermal growth factor receptor by ionizing radiation and modulation by SHP2.

Authors:  Lisa-Marie Sturla; George Amorino; Michael S Alexander; Ross B Mikkelsen; Kristoffer Valerie; Rupert K Schmidt-Ullrichr
Journal:  J Biol Chem       Date:  2005-02-11       Impact factor: 5.157

4.  Controlling epidermal growth factor (EGF)-stimulated Ras activation in intact cells by a cell-permeable peptide mimicking phosphorylated EGF receptor.

Authors:  M Rojas; S Yao; Y Z Lin
Journal:  J Biol Chem       Date:  1996-11-01       Impact factor: 5.157

5.  Ectodomain-specific E-cadherin antibody suppresses skin SCC growth and reduces tumor grade: a multitargeted therapy modulating RTKs and the PTEN-p53-MDM2 axis.

Authors:  Sabine M Brouxhon; Stephanos Kyrkanides; Veena Raja; Andrew Silberfeld; Xiaofei Teng; Denise Trochesset; Jason Cohen; Li Ma
Journal:  Mol Cancer Ther       Date:  2014-04-18       Impact factor: 6.261

6.  Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1.

Authors:  V Noë; B Fingleton; K Jacobs; H C Crawford; S Vermeulen; W Steelant; E Bruyneel; L M Matrisian; M Mareel
Journal:  J Cell Sci       Date:  2001-01       Impact factor: 5.285

7.  Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium.

Authors:  A F Olumi; G D Grossfeld; S W Hayward; P R Carroll; T D Tlsty; G R Cunha
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

8.  PATJ regulates tight junction formation and polarity in mammalian epithelial cells.

Authors:  Kunyoo Shin; Sam Straight; Ben Margolis
Journal:  J Cell Biol       Date:  2005-02-28       Impact factor: 10.539

9.  Soluble E-cadherin fragments increased in circulation of cancer patients.

Authors:  M Katayama; S Hirai; K Kamihagi; K Nakagawa; M Yasumoto; I Kato
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

Review 10.  EGF receptor trafficking: consequences for signaling and cancer.

Authors:  Alejandra Tomas; Clare E Futter; Emily R Eden
Journal:  Trends Cell Biol       Date:  2013-11-29       Impact factor: 20.808

View more
  14 in total

1.  Contribution of fibroblasts to tunnel formation and inflammation in hidradenitis suppurativa/ acne inversa.

Authors:  John W Frew; Kristina Navrazhina; Meaghan Marohn; Pei-Ju C Lu; James G Krueger
Journal:  Exp Dermatol       Date:  2019-07-03       Impact factor: 3.960

2.  Cancer cells corrupt normal epithelial cells through miR-let-7c-rich small extracellular vesicle-mediated downregulation of p53/PTEN.

Authors:  Weilian Liang; Yang Chen; Hanzhe Liu; Hui Zhao; Tingting Luo; Hokeung Tang; Xiaocheng Zhou; Erhui Jiang; Zhe Shao; Ke Liu; Zhengjun Shang
Journal:  Int J Oral Sci       Date:  2022-07-19       Impact factor: 24.897

3.  Long-term treatment with arsenite activates HER1 and HER2 through upregulating EGF, TGFα, and HSP90 in a human uroepithelial cell line.

Authors:  Peiyu Jin; Jieyu Liu; Qing Zhou; Sihao Li; Weijue Liu; Shuhua Xi
Journal:  Cell Biol Toxicol       Date:  2019-11-26       Impact factor: 6.691

4.  S100A4 Is Involved in Stimulatory Effects Elicited by the FGF2/FGFR1 Signaling Pathway in Triple-Negative Breast Cancer (TNBC) Cells.

Authors:  Maria Francesca Santolla; Marianna Talia; Marcello Maggiolini
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

5.  Cadherin-6B proteolysis promotes the neural crest cell epithelial-to-mesenchymal transition through transcriptional regulation.

Authors:  Andrew T Schiffmacher; Vivien Xie; Lisa A Taneyhill
Journal:  J Cell Biol       Date:  2016-11-17       Impact factor: 10.539

Review 6.  Proteases Revisited: Roles and Therapeutic Implications in Fibrosis.

Authors:  Jakub Kryczka; Joanna Boncela
Journal:  Mediators Inflamm       Date:  2017-05-31       Impact factor: 4.711

7.  ATM mutations and E-cadherin expression define sensitivity to EGFR-targeted therapy in colorectal cancer.

Authors:  Anna-Lena Geißler; Miriam Geißler; Daniel Kottmann; Lisa Lutz; Christiane D Fichter; Ralph Fritsch; Britta Weddeling; Frank Makowiec; Martin Werner; Silke Lassmann
Journal:  Oncotarget       Date:  2017-03-07

Review 8.  Microfabrication-Based Three-Dimensional (3-D) Extracellular Matrix Microenvironments for Cancer and Other Diseases.

Authors:  Kena Song; Zirui Wang; Ruchuan Liu; Guo Chen; Liyu Liu
Journal:  Int J Mol Sci       Date:  2018-03-21       Impact factor: 5.923

9.  Colorectal cysts as a validating tool for CAR therapy.

Authors:  Pierre Dillard; Maren Lie; Elizabeth Baken; Viola Hélène Lobert; Emmanuelle Benard; Hakan Köksal; Else Marit Inderberg; Sébastien Wälchli
Journal:  BMC Biotechnol       Date:  2020-06-01       Impact factor: 2.563

10.  Oncogenic transformation of normal breast epithelial cells co-cultured with cancer cells.

Authors:  Song Li; Jie Zhou; Hongying Wu; Qianying Lu; Yanhong Tai; Qiang Liu; Chenguang Wang
Journal:  Cell Cycle       Date:  2018-09-18       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.